Manufacturing

Feb 01, 2013
BioPharm International
Improvement strategy should be linked to business strategy.
Nov 01, 2012
BioPharm International
By BioPharm International Editors
Is process-centered organization in biopharmaceutical manufacturing a stepping stone or a stumbling block?
Oct 08, 2012
By BioPharm International Editors
Takeda's US subsidiary, Takeda America Holdings, is to acquire the vaccine specialist company LigoCyte Pharmaceuticals for an upfront payment of $60 million in a move intended to bolster and expand the company’s vaccine business.
Aug 01, 2012
BioPharm International
A one-day sign off for batch records is considered a best practice in the industry.
Jul 01, 2012
BioPharm International
Harmonized regulations call for a risk-based and systematic approach to evaluating and selecting CPPs.
Jun 01, 2012
BioPharm International
By BioPharm International Editors
Panayiotis P. Constantinides of Biopharmaceutical & Drug Delivery Consulting on growth of nanoparticle delivery systems.
Aug 01, 2009
BioPharm International
By BioPharm International Editors
Enabling site-wide process efficiency.
Jan 01, 2009
BioPharm International
FDA aims to regain public confidence in 2009.
Dec 01, 2008
BioPharm International
To expand coverage amidst the economic crisis, Obama will be looking hard for ways to cut healthcare costs.
Nov 01, 2008
BioPharm International
The FDA and other regulatory authorities are evaluating new regulations to ensure the safety and quality of nanomaterials in biomedical products.
native1_300x100
lorem ipsum